In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Clinical Trials - Diseases by specialty group
Solid Tumors 9
-
Protocol ID
- Associated disease
- Title
-
COG-APEC1621SC
- Ewing Sarcoma
- Germ Cell Tumors
- Hepatoblastoma
- Neuroblastoma
- Osteosarcoma
- Other Solid Tumor
- Retinoblastoma
- Rhabdomyosarcoma
- Wilms Tumor/Nephroblastoma
- NCI - COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
-
IIT-STEINECK-SARCAT-QOL
- Ewing Sarcoma
- Osteosarcoma
- Other Solid Tumor
- Rhabdomyosarcoma
- SARCAT-QOL: Patient Reported Quality of Life After Treatment for Pediatric High-Risk Bone and Soft Tissue Sarcomas
-
SPOC-2012-001
- Ewing Sarcoma
- Neuroblastoma
- Osteosarcoma
- Rhabdomyosarcoma
- Phase 1 Dose-Escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
-
COG-AGCT1531
- Germ Cell Tumors
- A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
-
COG-ALLIANCE-AGCT1532-P3BEP
- Germ Cell Tumors
- Phase 3 Accelerated BEP Trial: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumours
-
BCC-014-DFMO
- Neuroblastoma
- NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
-
BCC-015
- Neuroblastoma
- Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
-
COG-ALTE11C2
- Osteosarcoma
- Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy
-
COG-AREN1921
- Wilms Tumor/Nephroblastoma
- Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
